UY38009A - Proceso para la preparación de derivados de quinolina - Google Patents

Proceso para la preparación de derivados de quinolina

Info

Publication number
UY38009A
UY38009A UY0001038009A UY38009A UY38009A UY 38009 A UY38009 A UY 38009A UY 0001038009 A UY0001038009 A UY 0001038009A UY 38009 A UY38009 A UY 38009A UY 38009 A UY38009 A UY 38009A
Authority
UY
Uruguay
Prior art keywords
preparation
quinoline derivatives
new process
compounds
general formula
Prior art date
Application number
UY0001038009A
Other languages
English (en)
Inventor
Marc Nowakowski Dr
Frank Memmel
Florian Erver Dr
Thomas Himmler Dr
Andreas Karl Steib Dr
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of UY38009A publication Critical patent/UY38009A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Abstract

La presente invención se refiere a un nuevo proceso para preparar compuestos de quinolina de la fórmula general (II): en la cual Q, A, R4, R3 y R3’ son como se definen en el presente, así como los compuestos intermedios de dicho nuevo proceso.
UY0001038009A 2017-12-15 2018-12-14 Proceso para la preparación de derivados de quinolina UY38009A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17207586 2017-12-15

Publications (1)

Publication Number Publication Date
UY38009A true UY38009A (es) 2019-07-31

Family

ID=60673654

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038009A UY38009A (es) 2017-12-15 2018-12-14 Proceso para la preparación de derivados de quinolina

Country Status (17)

Country Link
US (1) US11505544B2 (es)
EP (1) EP3692037A1 (es)
JP (1) JP2021506774A (es)
KR (1) KR20200099548A (es)
AU (1) AU2018382999B2 (es)
BR (1) BR112020011901A2 (es)
CA (1) CA3085675A1 (es)
CL (1) CL2020001589A1 (es)
CO (1) CO2020007222A2 (es)
DO (1) DOP2020000118A (es)
IL (1) IL275216A (es)
MX (1) MX2020006185A (es)
PH (1) PH12020550905A1 (es)
SG (1) SG11202004260YA (es)
TW (1) TWI809018B (es)
UY (1) UY38009A (es)
WO (1) WO2019115768A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11560388B2 (en) 2019-03-19 2023-01-24 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic aza-benzothiophene and aza-benzofuran compounds
CA3179528A1 (en) * 2020-04-09 2021-10-14 Bayer Animal Health Gmbh Substituted condensed azines as anthelmintic compounds
EP4148052A1 (en) * 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
AR127495A1 (es) 2021-11-01 2024-01-31 Boehringer Ingelheim Vetmedica Gmbh Compuestos de pirrolopiridazina como antihelmínticos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU755707B2 (en) * 1997-12-22 2002-12-19 Pharmacia & Upjohn Company 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
CA2395772C (en) 1999-12-28 2010-09-28 Eisai Co., Ltd. Sulfonamide-containing heterocyclic compounds
JP4039856B2 (ja) 2000-02-03 2008-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 インテグリン発現阻害剤
JP2008214323A (ja) 2007-03-08 2008-09-18 Kyowa Hakko Kogyo Co Ltd 皮膚疾患の治療及び／または予防剤
US9006257B2 (en) 2012-02-09 2015-04-14 Glenmark Pharmaceuticals S.A. Bicyclic compounds as mPGES-1 inhibitors
AR098475A1 (es) * 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
CN106458974B (zh) * 2014-03-24 2019-07-16 广东众生药业股份有限公司 作为smo抑制剂的喹啉衍生物
EP3390384B1 (en) 2015-12-17 2021-09-15 Astex Therapeutics Limited Quinoline-3-carboxamides as h-pgds inhibitors
WO2018087036A1 (en) * 2016-11-11 2018-05-17 Bayer Animal Health Gmbh New anthelmintic quinoline-3-carboxamide derivatives

Also Published As

Publication number Publication date
MX2020006185A (es) 2020-09-03
JP2021506774A (ja) 2021-02-22
DOP2020000118A (es) 2020-08-31
KR20200099548A (ko) 2020-08-24
AU2018382999A1 (en) 2020-05-28
PH12020550905A1 (en) 2021-05-17
TWI809018B (zh) 2023-07-21
TW201927773A (zh) 2019-07-16
US11505544B2 (en) 2022-11-22
US20200308153A1 (en) 2020-10-01
CN111448192A (zh) 2020-07-24
RU2020123282A (ru) 2022-01-17
CO2020007222A2 (es) 2020-11-20
SG11202004260YA (en) 2020-06-29
EP3692037A1 (en) 2020-08-12
BR112020011901A2 (pt) 2020-11-24
CL2020001589A1 (es) 2020-11-20
CA3085675A1 (en) 2019-06-20
AU2018382999B2 (en) 2023-11-23
IL275216A (en) 2020-07-30
WO2019115768A1 (en) 2019-06-20

Similar Documents

Publication Publication Date Title
CO2018012171A2 (es) Piridinas sustituidas con heteroarilo y métodos de uso
DOP2020000118A (es) Proceso para la preparación de derivados de quinolina
CO2017008600A2 (es) Análogos de desacetoxitubulisina h, composiciones y método de producción de los mismos
MD3464249T2 (ro) Derivați carbonucleozidici substituiţi utili în calitate de agenți anticanceroşi
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
PH12015500263A1 (en) New bicyclic derivatives
MA38982A1 (fr) Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl
UY34955A (es) 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos
MX2014014531A (es) Derivados de aminoquinazolina y piridopirimidina.
MX2016007128A (es) Compuestos del receptor 6 de quimiocina (ccr6).
CY1122441T1 (el) Καινοτομες ενωσεις και συζευγματα κρυπτοφυκινης, η παρασκευη τους και η θεραπευτικη χρηση τους
CU24608B1 (es) Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas y métodos para preparar dichos compuestos
EA201791096A1 (ru) 4-оксо-3,4-дигидро-1,2,3-бензотриазины в качестве модуляторов gpr139
EA201791058A1 (ru) Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4)
CO2020002396A2 (es) Nuevos compuestos heterocíclicos fungicidas
SV2018005657A (es) "nuevos derivados de imidazo[4,5-b]piridina, un proceso para su preparacion y composiciones farmaceuticas que los contienen"
UY37932A (es) Proceso para producir compuestos de piridazinona herbicidas
CL2018000856A1 (es) Derivados de éter cíclico de pirazolo[1,5-a]pirimidin-3-carboxiamida.
EA201690294A1 (ru) Новые соединения и их применение для получения tau-визуализирующих агентов и tau-визуализирующих составов
CU20190035A7 (es) Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina
CU20180044A7 (es) Derivados novedosos de diamino piridina
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
EA201992360A1 (ru) Кристаллические формы (s)-афоксоланера
EA201591449A1 (ru) Способы получения противораковых композиций
MX2018009544A (es) Metodo para preparar derivados de 4-aminoindano sustituido.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20231114